Disease | leukemia |
Phenotype | C0026946|fungal disease |
Sentences | 4 |
PubMedID- 21482489 | Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature. |
PubMedID- 26366612 | Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an asian teaching hospital. |
PubMedID- 25689528 | Aim: we retrospectively analyzed 141 acute leukemia patients with unclassified invasive fungal disease episodes during chemotherapy to determine the optimum duration of antifungal treatment. |
PubMedID- 24644249 | In preventing invasive fungal disease (ifd) in patients with acute myelogenous leukemia (aml) or myelodysplastic syndrome (mds), clinical trials demonstrated efficacy of posaconazole over fluconazole and itraconazole. |
Page: 1